{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:34:15Z","timestamp":1760729655562},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T00:00:00Z","timestamp":1101772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1038\/sj.bjc.6602269","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T10:06:41Z","timestamp":1101809201000},"page":"1990-1992","source":"Crossref","is-referenced-by-count":4,"title":["Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis"],"prefix":"10.1038","volume":"91","author":[{"given":"A","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P F","family":"Ravetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R F","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O B","family":"Eden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,30]]},"reference":[{"key":"BF6602269_CR1","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood.V87.7.2649.bloodjournal8772649","volume":"87","author":"PD Aplan","year":"1996","unstructured":"Aplan PD, Chervinsky DS, Stanulla M, Burhans WC (1996) Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase 2 inhibitors. Blood 87: 2649\u20132658","journal-title":"Blood"},{"key":"BF6602269_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","volume":"1400","author":"CA Felix","year":"1998","unstructured":"Felix CA (1998) Secondary leukaemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta 1400: 233\u2013255","journal-title":"Biochim Biophys Acta"},{"key":"BF6602269_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/sj.leu.2401026","volume":"12","author":"CA Felix","year":"1998","unstructured":"Felix CA, Jones DH (1998) Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpoints. Leukemia 12: 976\u2013981","journal-title":"Leukemia"},{"key":"BF6602269_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter JI, Arico M, Egeler RM, Elinder G, Favera BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Web D (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 28: 342\u2013347","journal-title":"Med Pediatr Oncol"},{"key":"BF6602269_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mpo.1189","volume":"37","author":"J Kitazawa","year":"2001","unstructured":"Kitazawa J, Ito E, Arai K, Yokoyama M, Fukayama M, Imashuku S (2001) Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 37: 153\u2013154","journal-title":"Med Pediatr Oncol"},{"key":"BF6602269_CR6","doi-asserted-by":"publisher","first-page":"9802","DOI":"10.1073\/pnas.171309898","volume":"98","author":"BD Lovett","year":"2001","unstructured":"Lovett BD, Nigro LL, Rappaport EF, Blair IA, Osheroff N, Zheng N, Megonigal MD, Williams WR, Nowell PC, Felix CA (2001) Near-precise interchromosomal recombination and functional DNA topoisomerase 2 cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proc Natl Acad Sci USA 98: 9802\u20139807","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6602269_CR7","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1073\/pnas.050397097","volume":"97","author":"MD Megonigal","year":"2000","unstructured":"Megonigal MD, Cheung N-KV, Rappaport EF, Nowell PC, Wilson RB, Jones DH, Addya K, Leonard DGB, Kushner BH, Williams TM, Lange BJ, Felix CA (2000) Detection of leukaemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase 2 inhibitors. Proc Natl Acad Sci USA 97: 2814\u20132819","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6602269_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2141.2000.01843.x","volume":"109","author":"CH Pui","year":"2002","unstructured":"Pui CH, Relling MV (2002) Topoisomerase 2 inhibitor-related acute myeloid leukaemia. Br J Haematol 109: 13\u201323","journal-title":"Br J Haematol"},{"key":"BF6602269_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.1365-2141.1998.00677.x","volume":"101","author":"RF Stevens","year":"1998","unstructured":"Stevens RF, Hann IM, Wheatley K, Gray RG (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 101: 130\u2013140","journal-title":"Br J Haematol"},{"key":"BF6602269_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0925-5710(98)00070-X","volume":"68","author":"T Takahashi","year":"1998","unstructured":"Takahashi T, Yagasaki F, Endo K, Takahashi M, Itoh Y, Kawai N, Kusumoto S, Murohashi I, Bessho M, Hirashima K (1998) Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome. Int J Hematol 68: 333\u2013336","journal-title":"Int J Hematol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:13:39Z","timestamp":1684412019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,30]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BF6602269"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602269","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,30]]}}}